Literature DB >> 19688142

Spirometry in primary care case-identification, diagnosis and management of COPD.

David Price1, Alan Crockett, Mats Arne, Bernard Garbe, Rupert C M Jones, Alan Kaplan, Arnulf Langhammer, Siân Williams, Barbara P Yawn.   

Abstract

Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality worldwide, yet it remains significantly under-diagnosed. Systematic and opportunistic case-identification efforts in primary care, using questionnaires, careful assessment to identify symptoms, and follow-up spirometry, might improve diagnosis rates and enable earlier detection and management of COPD. The aims of spirometry performed for case-identification purposes are to exclude those patients with symptoms but normal lung function and identify those who require more complete investigation for COPD, including 'diagnostic standard' spirometry. Among patients with a confirmed diagnosis of COPD, spirometry monitoring is useful in identifying those with rapid deterioration in lung function who require further assessment. Spirometry in primary care can also support patient education and may encourage smoking cessation and treatment adherence.

Entities:  

Mesh:

Year:  2009        PMID: 19688142      PMCID: PMC6619278          DOI: 10.4104/pcrj.2009.00055

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  14 in total

1.  COPD in primary care.

Authors:  Noel Baxter; Christopher Cooper
Journal:  Br J Gen Pract       Date:  2012-06       Impact factor: 5.386

2.  Spirometry: an essential tool for screening, case-finding, and diagnosis of COPD.

Authors:  Erika J Sims; David Price
Journal:  Prim Care Respir J       Date:  2012-06

Review 3.  The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.

Authors:  Barbara Bp Yawn; Byron Thomashaw; David M Mannino; MeiLan K Han; Ravi Kalhan; Stephen Rennard; Scott Cerrata; James D Crapo; Robert Wise
Journal:  Chronic Obstr Pulm Dis       Date:  2017-07-15

Review 4.  Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.

Authors:  David B Price; Barbara P Yawn; Rupert C M Jones
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

Review 5.  Diagnosis and early detection of COPD using spirometry.

Authors:  David P Johns; Julia A E Walters; E Haydn Walters
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

6.  Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance.

Authors:  Roy A Pleasants; Khosrow Heidari; Anne G Wheaton; Jill A Ohar; Charlie Strange; Janet B Croft; Winston Liao; David M Mannino; Monica Kraft
Journal:  COPD       Date:  2015-09-14       Impact factor: 2.409

7.  FUMEPOC: early detection of chronic obstructive pulmonary disease in smokers.

Authors:  Vicente Gil-Guillén; Domingo Orozco-Beltrán; Concepcion V Carratala Munuera; Carlos Plaza-Sirvent; Patricia Lorca-Amorrich; Adriana López-Pineda; María P Vela-Troncoso; Juan J Soler; Manuel Yarza-Cañellas; Antonio Fernández; Luis Rosado-Bretón; Carmen Olivares-Bautista; Alejandro Muñoz-Fernández
Journal:  BMC Public Health       Date:  2011-05-31       Impact factor: 3.295

8.  Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD?

Authors:  Nicolas Molinari; Mathieu Abou-Badra; Grégory Marin; Chin-Long Ky; Noemi Amador; Anne Sophie Gamez; Isabelle Vachier; Arnaud Bourdin
Journal:  BMC Pulm Med       Date:  2015-04-28       Impact factor: 3.317

9.  COPD and disease-specific health status in a working population.

Authors:  Koichi Nishimura; Satoshi Mitsuma; Atsuko Kobayashi; Mikako Yanagida; Kazuhito Nakayasu; Yoshinori Hasegawa; Paul W Jones
Journal:  Respir Res       Date:  2013-06-02

10.  COPD Diagnostic Questionnaire (CDQ) for selecting at-risk patients for spirometry: a cross-sectional study in Australian general practice.

Authors:  Anthony J Stanley; Iqbal Hasan; Alan J Crockett; Onno C P van Schayck; Nicholas A Zwar
Journal:  NPJ Prim Care Respir Med       Date:  2014-07-10       Impact factor: 2.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.